RMTI logo

RMTI Rockwell Medical, Inc.

NASDAQ Capital Market · Drug Manufacturers - Specialty & Generic · Healthcare

$6.10
-0.51 (-7.72%)

Rockwell Medical, Inc., together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease. The company provides a range of therapies and products aimed at addressing iron deficiency and supporting hemodialysis procedures, serving markets both within the United States and internationally. A key offering includes its Trif…

Market Cap: $24.59Mwww.rockwellmed.com

Price

No data yet.

Social Signal Score

48
5d
—
30d
43
3 mentions
—
60d
50
6 mentions
—
90d
50
6 mentions
—
news: 6

Analyst Ratings

16 analysts
Buyconsensus
Strong Buy 0Buy 10Hold 2Sell 4Strong Sell 0
Avg price target$20+227.9%
Low $20Median $20High $20
Current Consensus

Revenue

$19.12M+42.81%
$13.24M$18.27M$23.29M$28.32M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-1.15
$-1.16–$-1.14
1 analysts
FY2026
$-1.51
$-1.53–$-1.49
1 analysts
FY2027
$-0.73
$-0.74–$-0.72
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Mark Strobeck
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
157
Beta
1.73
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-7.87
www.rockwellmed.com